BioSpace News Archive

Business

Neuronetics Reports Record Fourth Quarter and Record Full Year 2022 Financial and Operating Results

Neuronetics, Inc. today announced its financial and operating results for the fourth quarter and full year of 2022.

March 7, 2023
·
19 min read
Genetown

Dyne Therapeutics to Present at Upcoming Investor Conferences - March 7, 2023

Dyne Therapeutics, Inc.today announced that management is scheduled to participate in virtual fireside chats at the following investor conferences.

March 7, 2023
·
1 min read
BioMidwest

NeuroOne® Awarded U.S. Patent Covering Novel and Proprietary Thin Film Electrode Platform

NeuroOne Medical Technologies Corporation today announces it has been awarded a patent from the United States Patent and Trademark Office relating to its novel and proprietary electrode technology.

March 7, 2023
·
5 min read
Pharm Country

AnPac Bio Announces Receipt of the First Payment from a Malaysia Customer On a Signed US$1.5 Million Cancer Detection Equipment Purchase Contract

AnPac Bio-Medical Science Co., Ltd. announced today that it has received the first payment in late February 2023 from a Malaysian customer who had signed a US$1.5 million purchase contract for AnPac Bio’s Model AP9080 cancer detection devices.

March 7, 2023
·
6 min read
Business

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

Virax Biolabs Group Limited announced today that it has entered into an agreement for the distribution of an Avian Influenza A Virus (“AIV”) real-time PCR test kit to markets accepting the CE mark, namely the European Union.

March 7, 2023
·
4 min read
Business

ElevateBio Appoints Heidi L. Wagner, J.D., as Global Head of Government Affairs

ElevateBio, LLC today announced that Heidi L. Wagner, J.D., will be joining as Global Head of Government Affairs.

March 7, 2023
·
4 min read
Business

Korro Bio and Genevant Sciences Enter into Collaboration Agreement to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency

Korro Bio and Genevant Sciences today announced that they have entered into an agreement to combine Korro’s powerful RNA editing platform with Genevant’s industry-leading LNP technology to develop a differentiated therapeutic option for patients with Alpha-1 Antitrypsin Deficiency (AATD).

March 7, 2023
·
3 min read
POINT Biopharma Confirms No Disruptions to the Manufacturing and Clinical Supply for the 177Lu-PNT2002 SPLASH Trial, a Phase 3 Study in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)

POINT Biopharma Global Inc. today affirmed that the SPLASH clinical trial for the PSMA-targeted PNT2002 program is not experiencing any manufacturing or drug supply issues or delays.

March 7, 2023
·
4 min read
Business

Capsida Biotherapeutics Appoints Susan Catalano, Ph.D. as Chief Scientific Officer

Capsida Biotherapeutics Inc. (“Capsida”) today announced the appointment of Susan Catalano, Ph.D., as the company’s Chief Scientific Officer (CSO).

March 7, 2023
·
4 min read
Small Pharma to Host Virtual Roundtable Event with Key Opinion Leaders in Psychiatry

Small Pharma Inc. today announces that it will host a virtual Key Opinion Leader roundtable with Jerry Rosenbaum, MD, Professor of Psychiatry at Harvard Medical School, and David Erritzoe, MD, PhD, Imperial College London on Wednesday, March 15, 2023 at 2:00 p.m. EDT.

March 7, 2023
·
3 min read